Differential regulation of soluble and membrane CD40L proteins in T cells

被引:38
|
作者
Matthies, Kelli M. G.
Newman, Jodie L.
Hodzic, Alma
Wingett, Denise G. [1 ]
机构
[1] Boise State Univ, Dept Biol, Boise, ID 83725 USA
[2] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA
[3] MSTMRI Res Inst, St Lukes Reg Med Ctr, Boise, ID 83712 USA
关键词
CD4 T cells; cell surface molecules; cellular activation; CD40L;
D O I
10.1016/j.cellimm.2006.08.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD40 ligand is an important immunoregulatory protein expressed by T cells. This protein exists as two isoforms, a membrane glycoprotein and a truncated soluble form. Here we demonstrate that membrane and soluble CD40L (sCD40L) are differentially regulated depending upon the activation stimulus. In T cell receptor activated cells, both membrane and sCD40L proteins are expressed and CD28 costimulation further increases their expression. The dissection of TCR generated signals into calcium and PKC-dependent pathways demonstrates that calcium is sufficient to induce membrane CD40L yet insufficient for sCD40L. In contrast, sCD40L is preferentially induced by PKC. Moreover, sCD40L production is blocked by Zn2+-dependent metalloproteinase inhibitors while membrane CD40L is concurrently increased. This profile suggests the potential involvement of the ADAM-10 protease which was subsequently shown to cleave membrane CD40L to generate sCD40L. Given the role of sCD40L in numerous disease pathologies and its ability to activate proximal and distal immune responses, the regulated cleavage of CD40L may likely contribute to disease mechanisms. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 50 条
  • [21] Increased stability of CD40 ligand (CD40L) mRNA in SLE T cells.
    Kirou, KA
    Garofalo, G
    Kim, SJ
    George, SY
    Crow, MK
    Kirkland, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S486 - S486
  • [22] Soluble CD40L (CD154) is increased in patients with shock
    M. Chew
    M. Rahman
    L. Ihrman
    A. Erson
    S. Zhang
    H. Thorlacius
    Inflammation Research, 2010, 59 : 979 - 982
  • [23] CD40/CD40L and cardiovascular risk in patients on haemodialysis: a role for soluble CD40?
    Esposito, Pasquale
    Dal Canton, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2414 - 2415
  • [24] Effect of soluble CD40L on the activity of matrixmetalloproteinase 9 of MEG-01 cells
    Butta, N.
    Arias-Salgado, E.
    Alvarez, M.
    Martin, M.
    Fernandez, I
    Jimenez-Yuste, V
    Hernandez, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 951 - 952
  • [25] Soluble CD40L Release as Test for Functional Platelet Loss
    Wenzel, Folker
    Hohlfeld, Thomas
    Giers, Guenther
    CLINICAL LABORATORY, 2012, 58 (3-4) : 337 - 342
  • [26] Association between soluble CD40L and asymptomatic carotid plaque
    Novo, S
    Basili, S
    Tantillo, R
    Falco, A
    DAvi, V
    Novo, G
    Carlo, B
    Davi, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 283A - 283A
  • [27] Soluble CD40L induces VEGF secretion in synovial fibroblasts
    Capraru, MS
    Dragomir, E
    Voinea, M
    Rusu, C
    Capraru, D
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 130 - 130
  • [28] Upregulation of Membrane-Bound CD40L on CD4+ T cells in Women with Primary Sjogren's Syndrome
    Belkhir, R.
    Gestermann, N.
    Koutero, M.
    Seror, R.
    Tost, J.
    Mariette, X.
    Miceli-Richard, C.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (01) : 37 - 42
  • [29] Soluble CD40L Directly Regulates PMVEC Barrier Function
    Bauer, N. N.
    Baker, J. T.
    Rai, J.
    Moore, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [30] Soluble CD40L in plasma of patients with primary biliary cirrhosis
    Oertelt, S
    Invernizzi, P
    Selmi, C
    Podda, M
    Gershwin, ME
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 205 - 210